Oklo Inc. · NYSE:OKLO

Oklo — Q3 2024 Earnings Presentation

30 slides from Oklo's earnings presentation, Nov 14, 2024

  1. Slide 1: Q3 2024 Company Update

    Q3 2024 Company Update 1

  2. Slide 2: Forward-looking statements

    Forward-looking statements ABOUT THIS PRESENTATION This presentation is provided by Oklo Inc. (“Oklo”) for informational purposes only. The information contained herein does not purport to be all inclusive and no representations or warranties, express or implied, are given in, or in respect of, this

  3. Slide 3: Our mission is to provide clean, reliable, and affordable energy

    Our mission is to provide clean, reliable, and affordable energy on a global scale. 3

  4. Slide 4: Nuclear sector experiencing unprecedented tailwinds driven by A.I. power needs

    The nuclear sector is experiencing unprecedented tailwinds driven largely by A.I. power needs A.I. power use to expand significantly even with improvements in efficiency(1) Existing Nuclear Sites SMR Announcements Source: Goldman Sachs Global Investment Research, April 28, 2024 4

  5. Slide 5: Oklo aims to make it easier for data centers to procure low-carbon power

    Oklo aims to make it easier for data centers to procure the low- carbon power they want at scale Simple and Efficient Business Model Proven Commercial Technology • Based on EBR-II fast reactor technology • Low-cost design enabled by sodium coolant • Sourced from conventional energy supply chains • C

  6. Slide 6: Nuclear sector continues to receive massive government and commercial support

    The nuclear sector continues to receive massive support from government and now commercial financing Industry Momentum • Increased Financing Support for nuclear – 14 global financial institutions pledged support for nuclear power and accelerating adoption as part of the energy transition. • Bipartis

  7. Slide 7: Oklo strategic approach

    Oklo strategic approach Attractive Build, Own, Operate Business Model Selling power, not power plants, directly to customers under long- term contracts provides recurring revenues and a streamlined regulatory pathway. Business Model Modern, Small-Scale Design Our small, scalable designs combine the

  8. Slide 8: Oklo quarterly guidance framework

    Oklo quarterly guidance framework Reactor Licensing Progress Project Execution Fuel Fabrication & Recycling • NRC pre-application engagement • Progress on project development, • Commercialization milestones • Combined license applications (COLAs) construction and operations • Fuel fabrication facili

  9. Slide 9: Key milestones achieved in Q3 2024

    Key milestones achieved in Q3 2024 Reactor Licensing Progress Project Execution Fuel Fabrication & Recycling ✓ NRC pre-application engagement ✓ Finalized the DOE Agreement to ✓ U.S. DOE Approved Conceptual Safety advance siting at INL Design Report for Oklo’s Aurora Fuel Fabrication Facility ✓ Secur

  10. Slide 10: Oklo's regulatory & permitting progress

    Regulatory Licensing Progress Oklo’s regulatory & permitting progress 2019 2021 2024 • Safeguards Information Protection and • Began pre-application for fuel • Safety Design Strategy for the Aurora Fuel Fabrication Facility Handling Plan approved recycling approved by the DOE • Awarded recovered fue

  11. Slide 11: Integrated build, own, operate model enables streamlined regulatory pathway

    Regulatory Licensing Progress Oklo’s integrated build, own, operate business model expected to enable a streamlined regulatory pathway Typical Part 50 Construction Permit Operating License [Construction] Operate “2-part” License 24-36 Months 24-36 Months Expected 48-72 Months(2) A Recent Part 52 Des

  12. Slide 12: Regulatory paths & Oklo's permitting progress

    Regulatory Licensing Progress Regulatory paths & Oklo’s permitting progress Required reviews to construct & operate a nuclear facility Oklo’s NRC Regulatory Steps for Powerhouse What is completed in each Custom Combined Design Issue licensing project plan regulatory path License Application Certific

  13. Slide 13: Siting advancement for INL powerhouse deployment

    Project Execution Siting advancement for INL powerhouse deployment DOE Regulatory Steps for Siting Q3 Project Execution Updates Site Use Permit Began site preparation for first powerhouse following Formal siting request for DOE approval of preferred site agreement with the Department of Energy (DOE)

  14. Slide 14: DOE approval for Aurora fuel fabrication conceptual safety design report

    Fuel Fabrication & Recycling Oklo received DOE approval for Aurora fuel fabrication conceptual safety design report DOE Regulatory Steps for Fuel Steps to deployment of Aurora Fuel Fabrication Facility 1. Safety Design Strategy approval 2. Conceptual Safety Design Report approval 3. Preliminary Docu

  15. Slide 15: Powering AI: new letters of intent for up to 750MW

    Customer Pipeline Powering AI: Oklo has signed new non-binding letters of intent for up to 750MW with two data center customers • New Partnerships: Signed Letters of Intent for up to 750 MW with two major U.S. data center providers. • Deployment Model: Helps industries reduce reliance on traditional

  16. Slide 16: Oklo customer pipeline & PPA strategy

    Customer Pipeline Oklo customer pipeline & PPA strategy Oklo Customer Pipeline Continues to Grow (Megawatts) Growth since last quarter • Significant customer interest continues post consummation of business combination 2,100MW • Numerous commercial customer discussions underway; terms being worked p

  17. Slide 17: Oklo signs term sheet to acquire Atomic Alchemy

    Corporate & Business Development Oklo signs term sheet to acquire Atomic Alchemy A proposed exciting strategic acquisition enabling Oklo to enhance the economics of its recycling technology and facilitating the coproduction of valuable radioisotopes, which are essential inputs for several large, gro

  18. Slide 18: Atomic Alchemy is an innovative leader in radioisotopes

    Corporate & Business Development Atomic Alchemy is an innovative leader in radioisotopes A high-quality team that is commercializing its proprietary VIPR® technology to transform the radioisotope supply chain, addressing essential demands in healthcare, industry, research, defense and advanced semic

  19. Slide 19: Radioisotopes becoming a national strategic priority

    Corporate & Business Development Radioisotopes are becoming a national strategic priority for many nations, especially those facing acute shortages China(1) United Kingdom(2) (1) https://www.world-nuclear-news.org/articles/china-eyes-expansion-of-radioisotope-industry (2) Sources: https://www.bbc.co

  20. Slide 20: Radiopharmaceutical M&A demonstrates market demand for radioisotopes

    Corporate & Business Development Radiopharmaceutical M&A activity in the healthcare sector demonstrates market demand for radioisotopes Investment Buyer Target Comments “Radiopharmaceutical therapeutics are already transforming cancer care, and RayzeBio is at the forefront of pioneering the applicat

  21. Slide 21: Acquisition Highlights

    Corporate & Business Development Acquisition Highlights • Radioisotope technologies can significantly enhance the economics of nuclear fuel fabrication and recycling through sales of Complementary Technology high value radioisotope coproducts Massive Market Demand, • The radioisotope market is estim

  22. Slide 22: Lock-Up and Earnout triggers increased tradeable float

    Financials Lock-Up and Earnout triggers have increased Oklo’s tradeable float and reduced share overhang Lock-Up and Earnout Triggers Since 2Q Company Update Current Oklo Market Capitalization (1) (i) all Persons who hold one or more shares of Company Stock as of immediately prior to May 9, 2024 and

  23. Slide 23: Financial executive summary

    Financials Financial executive summary Key Q3 Financial Highlights 9/30 YTD 2024 Outlook Cash Used in Operating Activities Year-to-date cash used in operating activities sits at $24.9 million consisting of a net loss of $63.3 million inclusive of an increase of $2.2 million in working capital primar

  24. Slide 24: Future investor events

    Future investor events November 21, 2024 For more details on Oklo's conference and • Virtual – Jefferies New Nuclear Conference presentation participation see our Events & December 2-5, 2024 Presentations page on our investor relations • Scottsdale – UBS Global Technology and AI Conference website.

  25. Slide 25: Why Oklo?

    Why Oklo? Technology and Size Attractive Business Model Superior Economics Oklo’s technology is based on a proven fast reactor Selling power, not power plants, directly to customers Strategic design and engineering decisions result in technology with over 400 reactor years of combined under long-ter

  26. Slide 26: Thank You

    THANK YOU 26

  27. Slide 27: Q3 Condensed Consolidated Balance Sheets

    OKLO INC. Q3 CONDENSED CONSOLIDATED BALANCE SHEETS As of Financials September 30, 2024 December 31, 2023 (derived from (Unaudited) audited financials) Assets Current assets: Cash and cash equivalents $91,799,754 $9,867,588 Marketable securities 139,590,389 - Prepaid and other current assets 3,436,20

  28. Slide 28: Q3 Condensed Consolidated Statement of Operations

    OKLO INC. Q3 CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS Financials (unaudited) Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Operating expenses Research and development $5,049,070 $1,707,457 $19,428,854 $5,457,176 General and administrative 7,232,018 2,956,

  29. Slide 29: Q3 Condensed Consolidated Statement of Cash Flows

    OKLO INC. Q3 CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS Financials (unaudited) Nine Months Ended September 30, Operating and Investing Activities 2024 2023 Cash flows from operating activities Net loss $(63,327,233) $(17,851,758) Adjustments to reconcile net loss to net cash used in operating ac

  30. Slide 30: Q3 Statement of Cash Flows (Cont'd)

    OKLO INC. Q3 CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (CONT'D) Financials (unaudited) Financing Activities and Supplemental Disclosures Nine Months Ended September 30, 2024 2023 Cash flows from financing activities Proceeds from recapitalization $276,209,768 $- Proceeds from exercise of stock

Oklo — Q3 2024 Earnings Presentation on 6ix